Search
Search Results
-
Does health technology assessment compromise access to pharmaceuticals?
In response to rapidly rising pharmaceutical costs, many countries have introduced health technology assessment (HTA) as a ‘fourth hurdle’. We...
-
Unused, expired pharmaceuticals and their disposal practices among the general public in Burdur-Türkiye: a cross-sectional study
BackgroundUnused pharmaceuticals are currently a public health problem. This study aimed to identify unused pharmaceuticals, research practices about...
-
Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees
BackgroundTwo publicly available Swedish knowledge support systems, “Pharmaceuticals and Environment” on Janusinfo.se and Fass.se, provide...
-
Does health technology assessment compromise access to pharmaceuticals?
In response to rapidly rising pharmaceutical costs, many countries have introduced health technology assessment (HTA) as a ‘fourth hurdle’. We...
-
Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades
BackgroundThe timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to...
-
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
ObjectivesThe German Pharmaceutical Market Restructuring Act (AMNOG, 2011) is a two-stage process to regulate the price of new pharmaceuticals in...
-
Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential
BackgroundThe U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have published guidelines on the use of cancer treatments...
-
Knowledge, Perceptions and Attitudes among Sharia Practitioners in Palestine Regarding Halal Pharmaceuticals: An Exploratory Study
The purpose of this questionnaire-based cross-sectional study was to investigate the knowledge, perceptions, and attitudes regarding halal...
-
3D printing of pharmaceuticals: approach from bench scale to commercial development
BackgroundThe three-dimensional (3D) printing is paradigm shift in the healthcare sector. 3D printing is platform technologies in which complex...
-
Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review
BackgroundProcess intensification is a major hurdle in pharmaceutical process scale-up. Solvent removal strategies have limited the effectiveness of...
-
Pharmaceuticals in source waters of 95 First Nations in Canada
ObjectivesPharmaceuticals are emerging contaminants in the environment. Little has been published about the presence of pharmaceuticals in...
-
Emerging of artificial intelligence and technology in pharmaceuticals: review
BackgroundThe review covers a variety of Artificial intelligence (AI) related topics in medication development. Additionally, it gives a quick...
-
Microbiological quality of non-sterile pharmaceuticals in Egypt
BackgroundThe context and purpose of the study are as follows: Drug-borne infections may arise from non-adherence to strict microbiological quality...
-
Practices of anti-malaria pharmaceuticals inventory control system and associated challenges in public health facilities of Oromiya special zone, Amhara region, Ethiopia
BackgroundAnti-malaria pharmaceuticals inventory control system helps to maintain an appropriate stock level using logistics management information...
-
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
BackgroundThere have been ongoing efforts to understand when and how data from observational studies can be applied to clinical and regulatory...
